Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...
Bristol Myers Squibb and Johnson & Johnson have said they will stop development of their oral Factor XIa inhibitor milvexian in acute coronary syndrome after a disappointing trial result. The decision ...
New AWD Carrera 4S Coupé, Cabriolet, and Targa 4S debut with 480 PS Targa celebrates 60 years with signature roof and standard rear-wheel steering Upgraded tech includes GTS brakes, wireless charging, ...
KUALA LUMPUR: BMS Holdings Bhd made a lacklustre debut on the ACE Market of Bursa Malaysia today, opening below its initial public offering (IPO) price of 22 sen per share. The Johor-based building ...
Abstract: Pollution and fossil fuels are being strongly concerned. Electric vehicles were developed to solve a part of this problem. The source of energy used for electric vehicles is electricity, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback